Impact of Therapeutic Angiogenesis Using Autologous Bone Marrow-derived Mononuclear Cell Implantation in Patients with No-option Critical Limb Ischemia.

Yanishi, Kenji; Shoji, Keisuke; Fujioka, Ayumu; Hori, Yusuke; Yukawa, Arito; Matoba, Satoaki

Yanishi, Kenji; Shoji, Keisuke; Fujioka, Ayumu; Hori, Yusuke; Yukawa, Arito; Matoba, Satoaki.

Afiliação

Yanishi K; Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Japan.
Shoji K; Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Japan.
Fujioka A; Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Japan.
Hori Y; Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Japan.
Yukawa A; Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Japan.
Matoba S; Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Japan.

Ann Vasc Dis ; 13(1): 13-22, 2020 Mar 25.

Article em En | MEDLINE | ID: mdl-32273917

Palavras-chave

bone marrow-derived mononuclear cell; critical limb ischemia; no-option case; salvage rate; therapeutic angiogenesis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Ann Vasc Dis Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google